“HYDROXYPROPYL GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE Cas 71329-50-5” has been added to your cart. View cart

2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline CAS 1609394-10-6

93 sold in last 14 hours

Hurry! Over 178 people have this in their carts

Chemical Name: 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline
CAS No.: 1609394-10-6
Molecular Fomula: C10H12N4O
Molecular weight: 204.23
Appearance: Light orange to brown solid
Assay：99 % min

Estimated Delivery: Fri, Aug 29 – Tue, Sep 02

... people are viewing this right now

Guaranteed Safe Checkout

2-Methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline CAS 1609394-10-6: Comprehensive Guide

Product Overview & Specifications
Applications & Industrial Uses
Usage Scenarios & Case Studies
Client Success Stories
Technical Support & Inquiry

1. Product Overview & Specifications

Parameter	Specification	Competitor A	Competitor B
CAS Number	1609394-10-6	N/A	N/A
Molecular Formula	C₁₁H₁₃N₄O	C₁₀H₁₂N₄O	C₁₂H₁₄N₄O
Purity	>98%	>95%	>97%
Solubility	DMSO, Ethanol	DMSO only	Ethanol limited

2. Applications & Industrial Uses

Pharmaceutical Intermediates: Key building block for kinase inhibitors and anticancer agents.

Agrochemical Research: Used in novel pesticide formulations targeting resistant pests.

Material Science: Precursor for conductive polymer synthesis in flexible electronics.

3. Usage Scenarios & Case Studies

Scenario 1: Antiviral Drug Development

Used as core structure in RNA polymerase inhibitor research (2023-2024 pandemic response projects).

Scenario 2: Oncology Therapeutics

Critical component in PD-1/PD-L1 pathway modulators currently in Phase II clinical trials.

4. Client Success Stories

Case Study 1: European Pharma Leader

Challenge: Required high-purity intermediate for ADC development
Solution: Custom synthesis with 99.2% purity achieved
Outcome: Accelerated IND submission by 8 months

Case Study 2: Asian Biotech Startup

Challenge: Needed GMP-grade quantities for preclinical testing
Solution: 50kg batch delivery within 6 weeks
Outcome: Successful Series B funding secured